Aligos Therapeutics
BiotechnologySan Francisco, California, United StatesPost-IPO Equity$505.6M total fundingwww.aligos.com
Latest funding:$105.0M · Post-IPO Equity (February 12, 2025)
Angel investors who backed Aligos Therapeutics
27 investors in our database backed Aligos Therapeutics.
Albert Cha
Chairman
Frank Kung
Co-Founder and Managing Partner
Gaurav Aggarwal
Chief Investment Officer - Opportunity Fund
Michael Chang
Managing Partner
Nina Feng
Principal
Lawrence Wang
Managing Director
Mahendra Shah
Managing Director
Andrew Goldberg
Principal
Chen Yu
Managing Partner
Qi Zhu
Head of Talent Development
Brian Atwood
Founder, CEO
Charles Warden
Managing Director
Ross Jaffe
Managing Director
Joel Drewry
Principal
Robin Praeger
Managing Director/Advisor
Bill Link
investor
Don Milder
Managing Partner
Beckie Robertson
Founder and General Partner
Barbara Lubash
Managing Director (Emeritus) and Co-Founder
Rachel Lane PhD
Chief Business Officer
guido magni
Partner ,Versant Ventures
Clare Ozawa
Managing Director
Brad Bolzon
Chairman, Managing Director
Alexander Mayweg
Managing Director
Paul Grayson
Partner
Fang Ni
Principal
Dominik Naczynski
Managing Director
Find the right investors for your startup
Search thousands of angel investors and VCs by industry, stage, check size, and location — and see who backed companies like Aligos Therapeutics.
Search investors